AI in care NKI is actively developing AI-driven tools (e.g., BrainMets AI and mesothelioma treatment response models) to enhance diagnostic accuracy and treatment planning, presenting a compelling opportunity to offer AI/ML data processing, integration with existing workflows, and cloud-enabled analytics services.

Clinical research integration The institute operates at the intersection of cutting-edge research and patient care within one campus, creating demand for research informatics, data governance, and clinical trial management solutions that streamline data sharing between researchers and clinicians.

Strategic partnerships Active collaborations with international partners, patient organizations, and pharma/biotech groups (e.g., MRM Health, Oncode Institute, SITC) indicate opportunities to provide collaborative data platforms, translational research support, and joint grant/ funded project manage services.

Cloud and analytics readiness NKI’s tech stack includes AWS, Google Cloud Platform, Databricks, SAS, Kubernetes, and VMware, signaling an openness to advanced cloud-based analytics, data lake modernization, model deployment, and secure data infrastructure services.

Funding and growth signals High-profile research leadership and award recognition (Spinoza Prize) alongside ongoing AI and imaging initiatives point to a scalable opportunity for premium research software, high-value analytics licenses, and professional services around AI model development and deployment.